Physician profile
John A Mckeating
NPI 1205808052
$2,005.69
in general payments reported to CMS, 2019-2025
8 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $15.32 · 2023: $38.64 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $799 · Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $798.96 |
| Food and Beverage | $340.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,679.56 | 2019-2025 | |
| Davol INC. | $97.68 | 2025 | Arista |
| W. L. Gore & Associates, INC. | $92.47 | 2025 | Gore Synecor Biomaterial |
| Integra Lifesciences Corporation | $53.96 | 2020-2023 | Integra, Surgimend, Omnigraft |
| Becton, Dickinson and Company | $39.35 | 2025 | Phasix Mesh |
| Tela Bio, INC. | $17.90 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $13.29 | 2019 | |
| Ethicon US, LLC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mckeating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.